Targeting BCL-W and BCL-XL as a therapeutic strategy for Hodgkin lymphoma.

Adams CM, Mitra R, Vogel AN, Liu J, Gong JZ, Eischen CM. Targeting BCL-W and BCL-XL as a therapeutic strategy for Hodgkin lymphoma. Leukemia. 2019 Oct 21.

View in: PubMed